Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a simple matter of exercise.

Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.

Celebrities have access to doctors that most others don’t,” Jameela Jamil flags the risks of GLP-1s like those Serena ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.

Tennis champion Serena Williams has divided the internet after revealing she’s been using a GLP-1 weight loss drug. The ...

Serena Williams turned to a weight loss medication and it is paying off massively as the American tennis icon reveals she ...